The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The safety and efficacy of immune checkpoint inhibitor rechallenge after immune-related adverse events in stage IV NSCLC patients.
 
Mengni Guo
No Relationships to Disclose
 
Ari M. Vanderwalde
Employment - Caris Life Sciences
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Compugen; Concerto HealthAI; Elsevier; Inivata
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Immunomedics/Gilead (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Replimune (Inst)
 
Xinhua Yu
No Relationships to Disclose
 
Gregory A. Vidal
Employment - Novartis (I)
Stock and Other Ownership Interests - Oncodisc
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; bioTheranostics; Genentech; Immunomedics; Lilly; Myriad Genetics; Novartis; Puma Biotechnology
Speakers' Bureau - Lilly
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Celcuity; Daiichi Sankyo; EMD Serono; Genentech/Roche; Lilly; Myriad Genetics; Natera; Puma Biotechnology; Tesaro
 
Gary G. Tian, MD
Stock and Other Ownership Interests - Arcus Biosciences; BeiGene; Cassava Sciences; G1 Therapeutics; Guardant Health; Immutep; Moderna Therapeutics; Natera; Veru
Consulting or Advisory Role - Aptitude Health; Cardinal Health; Curio Science